Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Pediatric Surgery International
|
October 20, 1999
A method to overcome the inability to draw blood from central venous lines in children
A Nawaz, H Matta, A Jacobsz, et al.
Pediatric Surgery International
|
April 29, 2000
Congenital pyloric atresia and junctional epidermolysis bullosa: a report of two cases
A Nawaz, H Matta, A Jacobsz, et al.
Developmental Cognitive Neuroscience
|
November 14, 2017
Making an unknown unknown a known unknown: Missing data in longitudinal neuroimaging studies
Tyler H Matta, John C Flournoy, Michelle L Byrne
Annals of Saudi Medicine
|
February 6, 2007
Acute hydrops of the gallbladder in a 10-year-old boy with infectious hepatitis
A Nawaz, H Matta, A Jacobsz, et al.
Fertility and Sterility
|
January 1, 1988
Endocrinologic and clinical evaluation following a single administration of a gonadotrophin-releasing hormone agonist (Zoladex), in a depot formulation, to premenopausal women
W H Matta, R W Shaw, G D Burford
Oncogene
|
January 19, 2006
Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation
Q Sun, H Matta, G Lu, et al.
Clinical Endocrinology
|
July 1, 1988
Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women
W H Matta, R W Shaw, R Hesp, et al.
Fertility and Sterility
|
June 1, 1988
Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin
W H Matta, I Stabile, R W Shaw, et al.
British Medical Journal (Clinical Research Ed.)
|
June 13, 1987
Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women
W H Matta, R W Shaw, R Hesp, et al.
Oncogene
|
June 30, 2015
Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors
R Gopalakrishnan, H Matta, B Tolani, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Pediatric Surgery International
|
October 20, 1999
A method to overcome the inability to draw blood from central venous lines in children
A Nawaz, H Matta, A Jacobsz, et al.
Pediatric Surgery International
|
April 29, 2000
Congenital pyloric atresia and junctional epidermolysis bullosa: a report of two cases
A Nawaz, H Matta, A Jacobsz, et al.
Developmental Cognitive Neuroscience
|
November 14, 2017
Making an unknown unknown a known unknown: Missing data in longitudinal neuroimaging studies
Tyler H Matta, John C Flournoy, Michelle L Byrne
Annals of Saudi Medicine
|
February 6, 2007
Acute hydrops of the gallbladder in a 10-year-old boy with infectious hepatitis
A Nawaz, H Matta, A Jacobsz, et al.
Fertility and Sterility
|
January 1, 1988
Endocrinologic and clinical evaluation following a single administration of a gonadotrophin-releasing hormone agonist (Zoladex), in a depot formulation, to premenopausal women
W H Matta, R W Shaw, G D Burford
Oncogene
|
January 19, 2006
Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation
Q Sun, H Matta, G Lu, et al.
Clinical Endocrinology
|
July 1, 1988
Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women
W H Matta, R W Shaw, R Hesp, et al.
Fertility and Sterility
|
June 1, 1988
Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin
W H Matta, I Stabile, R W Shaw, et al.
British Medical Journal (Clinical Research Ed.)
|
June 13, 1987
Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women
W H Matta, R W Shaw, R Hesp, et al.
Oncogene
|
June 30, 2015
Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors
R Gopalakrishnan, H Matta, B Tolani, et al.
Page
of 5